Cargando…
Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107179/ https://www.ncbi.nlm.nih.gov/pubmed/35580654 http://dx.doi.org/10.1016/j.kint.2022.05.004 |
_version_ | 1784708434565791744 |
---|---|
author | Anft, Moritz Blazquez-Navarro, Arturo Frahnert, Michael Fricke, Lutz Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina |
author_facet | Anft, Moritz Blazquez-Navarro, Arturo Frahnert, Michael Fricke, Lutz Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina |
author_sort | Anft, Moritz |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9107179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | International Society of Nephrology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91071792022-05-16 Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses Anft, Moritz Blazquez-Navarro, Arturo Frahnert, Michael Fricke, Lutz Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-07 2022-05-14 /pmc/articles/PMC9107179/ /pubmed/35580654 http://dx.doi.org/10.1016/j.kint.2022.05.004 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Anft, Moritz Blazquez-Navarro, Arturo Frahnert, Michael Fricke, Lutz Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses |
title | Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses |
title_full | Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses |
title_fullStr | Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses |
title_full_unstemmed | Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses |
title_short | Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses |
title_sort | inferior cellular and humoral immunity against omicron and delta variants of concern compared with sars-cov-2 wild type in hemodialysis patients immunized with 4 sars-cov-2 vaccine doses |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107179/ https://www.ncbi.nlm.nih.gov/pubmed/35580654 http://dx.doi.org/10.1016/j.kint.2022.05.004 |
work_keys_str_mv | AT anftmoritz inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT blazqueznavarroarturo inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT frahnertmichael inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT frickelutz inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT meistertonil inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT rochtoralf inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT stervboulrik inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT pfaenderstephanie inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT westhofftimmh inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses AT babelnina inferiorcellularandhumoralimmunityagainstomicronanddeltavariantsofconcerncomparedwithsarscov2wildtypeinhemodialysispatientsimmunizedwith4sarscov2vaccinedoses |